Top Markets
#1 Islamic Coin Islamic Coin +154.29%
#2 PulseChain PulseChain +49.22%
#3 BOOK OF MEME BOOK OF MEME +28.39%
#4 Bio Protocol Bio Protocol +19.24%
#5 RedStone RedStone +16.42%
#6 edgeX edgeX +15.84%
#7 Janction Janction +14.03%
#8 rsERG rsERG +12.18%
#9 SkyAI SkyAI +11.75%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.69%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
Bio Preventive Medicine Corp. Bio Preventive Medicine Corp.

Bio Preventive Medicine Corp.

6810
株式のランク #27176
Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical... Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.
株価
$0.70116857
時価総額
$34.67M
変化（1日）
-1.78%
変化（1年）
-18.30%
国
TW
取引 Bio Preventive Medicine Corp. (6810)

カテゴリー

Healthcare
Bio Preventive Medicine Corp.（6810）の利益
2026 時点の利益 TTM: 0
Bio Preventive Medicine Corp. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Bio Preventive Medicine Corp. の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH